Account
Inquiry
Tirzepatide 20mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This pharmaceutical grade peptide is supplied as white lyophilized powder with 99% purity for research purposes only.
As a dual agonist, tirzepatide 20mg combines the effects of two important incretin hormones in a single molecule. The compound demonstrates superior efficacy in glucose control and weight management compared to single receptor agonists. Research indicates tirzepatide 20mg may help reduce hemoglobin A1c levels while suppressing appetite and delaying gastric emptying.
The tirzepatide 20mg peptide features a modified lysine side chain with PEGylation, which enhances water solubility and extends biological half-life. Clinical studies show significant weight reduction effects comparable to bariatric surgery when administered at proper dosages.
Our tirzepatide 20mg is produced under strict GMP conditions and undergoes rigorous quality control testing. The product is supplied in sterile vials with proper lyophilization to ensure stability and longevity. Each batch is accompanied by comprehensive analytical documentation.
Key research applications of tirzepatide 20mg include: studying mechanisms of glucose-dependent insulin secretion, investigating weight management pathways, exploring potential treatments for type 2 diabetes, and metabolic syndrome research.
For research use only. Not for human consumption. Proper storage at -20°C is recommended to maintain product integrity. Our facility offers bulk quantities and custom synthesis options for qualified research institutions.
